Company Name or Ticker Symbol
Search for other Categories
Amyris, Inc.  (AMRS)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs
Price: $3.5300 $0.44 14.239%
Day's High: $ 3.67 Week Perf: 11.36 %
Day's Low: $ 3.15 30 Day Perf: 17.67 %
Volume (M): 731 52 Wk High: $ 4.32
Volume (M$): $ 2,581 52 Wk Avg: $ 1.79
Open: 3.20 52 Wk Low: 0.21
  AMRS Charts & Quotes
You need to upgrade your Flash Player

 Market Capitalization (Millions $) 82
 Shares Outstanding (Millions) 23
 Employees 440
 Revenues (TTM) (Millions $) 87
 Net Income (TTM) (Millions $) -105
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 0
Amyris, Inc.
Amyris, Inc. is a leading integrated industrial biotechnology company that is applying its technology platform to engineer, manufacture and sell high performance, low cost products into the Health and Nutrition, Personal Care and Performance Materials markets. Our proven technology platform allows us to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into large volume, high-value ingredients. Our biotechnology platform and industrial fermentation process replaces existing complex and expensive chemical manufacturing processes. We believe industrial synthetic biology represents a third industrial revolution, bringing together biology and engineering to generate new, more sustainable materials to meet the growing global demand for bio-based replacements for petroleum, animal- or plant-derived ingredients. We continue to build demand for our current portfolio of products through a sales network comprised of direct sales and distributors, and are engaged in collaborations across each of our three market focus areas to drive additional product sales and partnership opportunities. Via our partnership model, we co-invest in the development of each molecule to bring it from the lab to commercial scale and then capture long term revenue either via the sale of the molecule to the partner and/or value sharing of end product sales.

AMRS is expected to report next financial results on February 13, 2018.

Amyris's Segments
Company Estimates
  Revenue Outlook
   Amyris does not issue revenue guidance.

  Earnings Outlook
   Amyris, Inc. does not provide earnings estimates.  


Ametek Inc

Sales and Eps Grew in Double Digits

Company reported double digit Sales and earnings growth in the third quarter. Sales were at $1.08 billions up by 14.79 % year on year and increased by 1.9 % quarter on quarter, while income increased by 17.86 % to $0.66, sequentially income improved by 1.54 %.

Unifi Inc

Decline in Earnings while Sales Grew

Sales growth of 2.67 %, could not prevent income contraction of -5.88 % in the first quarter, compare to same quarter a year ago. Sales were at $164.24 millions and eps at $0.48.

AMRS's Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.93
Price to Sales (Expected) -
Price to Book -
AMRS's Financial Strength Current
Quick Ratio 0.17
Working Capital Ratio 0.65
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -
Per Share Current
Earnings (TTM) -0.82 $
Revenues (TTM) 3.78 $
Cash Flow (TTM) 0.18 $
Cash 0.45 $
Book Value -8.61 $
Dividend (TTM) 0 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
AMRS's Efficiency Current
Revenue per Employee (TTM) 198,730
Net Income per Employee (TTM) -239,116
Receivable Turnover Ratio (TTM) 8.15
Inventory Turnover Ratio (TTM) 10.05
Asset Turnover Ratio (TTM) 0.8
AMRS's Profitability Ratio Current
Gross Margin 32.71 %
Operating Margin -
Net Margin 2.41 %
Net Cash Flow Margin 14.72 %
Effective Tax Rate (TTM) -
Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Payout Ratio (TTM) -
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness

You need to upgrade your Flash Player

You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

AVNI's Profile

Stock Price

AVNI's Financials

AVNI's Expectations

Business Description


Charts & Quotes

AVNI's News


AVNI's Competitors

Customers & Markets

Economic Indicators

AVNI's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength



Management Effectivness


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com